80 related articles for article (PubMed ID: 10544224)
21. [Recognising hereditary non-polyposis colorectal cancer without a clear family history].
de Bruin JH; Nagengast FM; Ligtenberg MJ; van Krieken JH; Niermeijer MF; Hoogerbrugge N
Ned Tijdschr Geneeskd; 2004 Oct; 148(42):2053-7. PubMed ID: 15532325
[TBL] [Abstract][Full Text] [Related]
22. Genetic susceptibility to non-polyposis colorectal cancer.
Lynch HT; de la Chapelle A
J Med Genet; 1999 Nov; 36(11):801-18. PubMed ID: 10544223
[TBL] [Abstract][Full Text] [Related]
23. [Hereditary nonpolyposis colorectal carcinoma (HNPCC). Current review of etiology, clinical aspects, diagnosis and therapy].
al-Taie O; Mörk H; Seufert J; Treis H; Jakob F; Scheurlen M
Med Klin (Munich); 2001 Sep; 96(9):529-38. PubMed ID: 11603116
[TBL] [Abstract][Full Text] [Related]
24. Prostate cancer is part of the hereditary non-polyposis colorectal cancer (HNPCC) tumor spectrum.
Soravia C; van der Klift H; Bründler MA; Blouin JL; Wijnen J; Hutter P; Fodde R; Delozier-Blanchet C
Am J Med Genet A; 2003 Aug; 121A(2):159-62. PubMed ID: 12910497
[TBL] [Abstract][Full Text] [Related]
25. Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures.
Wagner A; van Kessel I; Kriege MG; Tops CM; Wijnen JT; Vasen HF; van der Meer CA; van Oostrom II; Meijers-Heijboer H
Fam Cancer; 2005; 4(4):295-300. PubMed ID: 16341806
[TBL] [Abstract][Full Text] [Related]
26. An update of HNPCC (Lynch syndrome).
Lynch HT; Smyrk T; Lynch J
Cancer Genet Cytogenet; 1997 Jan; 93(1):84-99. PubMed ID: 9062584
[TBL] [Abstract][Full Text] [Related]
27. Current approaches in hereditary nonpolyposis colorectal cancer.
Lynch PM
J Natl Compr Canc Netw; 2012 Aug; 10(8):961-7. PubMed ID: 22878821
[TBL] [Abstract][Full Text] [Related]
28. Direct mutational analysis in a family with hereditary non-polyposis colorectal cancer.
Van de Water NS; Jeevaratnam P; Browett PJ; Stewart SM; Lane MR; Jass JR
Aust N Z J Med; 1994 Dec; 24(6):682-6. PubMed ID: 7717919
[TBL] [Abstract][Full Text] [Related]
29. High throughput genetic screening for the detection of hereditary non-polyposis colon cancer (HNPCC) using capillary electrophoresis.
Merkelbach-Bruse S; Köse S; Losen I; Bosserhoff AK; Buettner R
Comb Chem High Throughput Screen; 2000 Dec; 3(6):519-24. PubMed ID: 11121520
[TBL] [Abstract][Full Text] [Related]
30. Copy number variation in hereditary non-polyposis colorectal cancer.
Masson AL; Talseth-Palmer BA; Evans TJ; Grice DM; Duesing K; Hannan GN; Scott RJ
Genes (Basel); 2013 Sep; 4(4):536-55. PubMed ID: 24705261
[TBL] [Abstract][Full Text] [Related]
31. Value of predictive genetic testing in management of hereditary non-polyposis colorectal cancer (HNPCC).
Stanley AJ; Gaff CL; Aittomäki AK; Fabre LC; Macrae FA; St John J
Med J Aust; 2000 Apr; 172(7):313-6. PubMed ID: 10844916
[TBL] [Abstract][Full Text] [Related]
32. The effect of family size on estimates of the frequency of hereditary non-polyposis colorectal cancer.
Percesepe A; Anti M; Roncucci L; Armelao F; Marra G; Pahor M; Coco C; Gasbarrini G; Ponz de Leon M
Br J Cancer; 1995 Nov; 72(5):1320-3. PubMed ID: 7577490
[TBL] [Abstract][Full Text] [Related]
33. No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer.
Renkonen-Sinisalo L; Sipponen P; Aarnio M; Julkunen R; Aaltonen LA; Sarna S; Järvinen HJ; Mecklin JP
Scand J Gastroenterol; 2002 May; 37(5):574-7. PubMed ID: 12059060
[TBL] [Abstract][Full Text] [Related]
34. Suggested screening guidelines for familial colorectal cancer.
Hodgson SV; Bishop DT; Dunlop MG; Evans DG; Northover JM
J Med Screen; 1995; 2(1):45-51. PubMed ID: 7497146
[TBL] [Abstract][Full Text] [Related]
35. Investigating of microsatellites instability in patients with hereditary non-polyposis colorectal cancer in Isfahan.
Homayouni V; Salehi M; Kazemi M
Adv Biomed Res; 2014; 3():145. PubMed ID: 25161992
[TBL] [Abstract][Full Text] [Related]
36. Age and origin of two common MLH1 mutations predisposing to hereditary colon cancer.
Moisio AL; Sistonen P; Weissenbach J; de la Chapelle A; Peltomäki P
Am J Hum Genet; 1996 Dec; 59(6):1243-51. PubMed ID: 8940269
[TBL] [Abstract][Full Text] [Related]
37. Predictive genetic testing of first degree relatives of mutation carriers is a cost-effective strategy in preventing hereditary non-polyposis colorectal cancer in Singapore.
Wang VW; Koh PK; Chow WL; Lim JF
Fam Cancer; 2012 Jun; 11(2):279-89. PubMed ID: 22350504
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of genetic testing for hereditary non-polyposis colorectal cancer (HNPCC).
Walpole IR
Med J Aust; 2000 Apr; 172(7):308-9. PubMed ID: 10844913
[No Abstract] [Full Text] [Related]
39. A comparison of multi-layer neural network and logistic regression in hereditary non-polyposis colorectal cancer risk assessment.
Kokuer M; G Naguib R; Jancovic P; Banfield Younghusband H; Green R
Conf Proc IEEE Eng Med Biol Soc; 2005; 2005():2417-20. PubMed ID: 17282725
[TBL] [Abstract][Full Text] [Related]
40. Erratum: Scarce evidence of the causal role of germline mutations in UNC5C in hereditary colorectal cancer and polyposis.
Mur P; Sánchez-Cuartielles E; Aussó S; Aiza G; Valdés-Mas R; Pineda M; Navarro M; Brunet J; Urioste M; Lázaro C; Moreno V; Capellá G; Puente XS; Valle L
Sci Rep; 2016 Apr; 6():23880. PubMed ID: 27096942
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
